Benign Atypical Hyperplasia Indicator of Higher Breast Cancer Risk in Women
Hartmann said that experts have long known that atypical hyperplasia is associated with increased odds for breast cancer but their study sheds light on the extent of this risk. The researcher said that the cancer risks of women in this group can be ...
Tech Times - Mon, 05 Jan 2015 05:52

Atypical hyperplasia bigger breast cancer risk factor than previously thought ...
Fox News - Fri, 02 Jan 2015 07:45

Benign Atypical Hyperplasia Not So Benign After All as it Carries High Breast ...
News Every day - Fri, 02 Jan 2015 23:30

MRI and Mammogram Screenings Catch Cancer Early
dailyRx - Fri, 02 Jan 2015 09:48

Atypical Hyperplasia Tied to Increased Risk of Breast Cancer
Headlines & Global News - Fri, 02 Jan 2015 07:19

Risk of Breast Cancer in Women With Atypical Hyperplasia Better Defined
Medical Research News and Interviews on MedicalResearch.com (blog) - Sat, 03 Jan 2015 07:22

Celonova Biosciences Receives CE Mark to Benign Prostatic Hyperplasia ...
San Antonio, Texas-based CeloNova BioSciences, Inc., has been granted European expanded indication (CE Mark) from the European Commission regarding its medication EMBOZENE embolic microspheres to include benign prostatic hyperplasia (BPH) as ...
BioNews Texas - Fri, 16 Jan 2015 05:52

CeloNova BioSciences Receives Expanded Indication for Benign Prostatic ...
SAN ANTONIO--(BUSINESS WIRE)-- CeloNova BioSciences, Inc., today announced that it has received an expanded indication (CE Mark) in Europe for its EMBOZENETM embolic microspheres to include the treatment of benign prostatic hyperplasia (BPH).
Financial Mirror - Wed, 14 Jan 2015 07:11



Study Finds Women With Atypical Hyperplasia Have Increased Risk of Breast ...
shutterstock_201129470 A recent study from Mayo Clinic researchers, published in the New England Journal of Medicine has shown that women who are diagnosed with atypical hyperplasia of the breast (atypia) have an increased risk of developing breast ...
Breast Cancer News - Tue, 06 Jan 2015 03:23

Atypical hyperplasia ups breast cancer risk
When it occurs in a distorted pattern, it's called atypical hyperplasia. This condition is found in about one-tenth of the more than one million breast biopsies with benign findings done in the United States each year, according to researchers from the ...
Deccan Herald - Tue, 20 Jan 2015 10:42

Neurocrine Biosciences Announces Oral Presentation of NBI-77860 Clinical ...
20, 2015 /PRNewswire/ -- Neurocrine Biosciences, Inc. NBIX, -0.03% announced today that the steering committee of ENDO 2015 has selected the abstract of their recently completed clinical study of NBI-77860 in classic congenital adrenal hyperplasia for ...
MarketWatch - Tue, 20 Jan 2015 05:17

Neurocrine Biosciences Announces Granting of Orphan Drug Status for NBI ...
"We are very pleased that the FDA has granted NBI-77860 orphan status to treat congenital adrenal hyperplasia, a devastating disease that is a significant challenge for both clinicians and patients," said Malcolm Lloyd-Smith, Chief Regulatory Officer ...
PR Newswire (press release) - Fri, 16 Jan 2015 11:30



Women With Benign Breast Diseases Are At A High Risk To Develop Breast ...
Women with atypical hyperplasia, which is a type of benign breast disease, are at a higher risk of breast cancer. Atypical hyperplasia is a condition where abnormal growth of breast cells is observed and is considered as a forerunner for breast cancer.
International Business Times AU - Thu, 29 Jan 2015 08:23


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014